SG/CALL/IDEXX LABORATORIES/690/0.1/19.12.25 Share Price

Warrant

DE000SU5L845

Real-time Boerse Frankfurt Warrants 13:07:33 23/05/2024 BST
4.47 EUR -2.19% Intraday chart for SG/CALL/IDEXX LABORATORIES/690/0.1/19.12.25
Current month+17.48%
1 month+16.88%
Date Price Change
23/05/24 4.47 -2.19%
22/05/24 4.57 -1.08%
21/05/24 4.62 -5.13%
20/05/24 4.87 -9.31%
17/05/24 5.37 -0.37%

Real-time Boerse Frankfurt Warrants

Last update May 23, 2024 at 01:07 pm

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying IDEXX LABORATORIES, INC.
IssuerLogo Issuer Société Générale Société Générale
WKN SU5L84
ISINDE000SU5L845
Date issued 12/12/2023
Strike 690 $
Maturity 19/12/2025 (575 Days)
Parity 10 : 1
Emission price 6.65
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 8.92
Lowest since issue 2.93
Spread 0.45
Spread %9.15%

Company Profile

IDEXX Laboratories, Inc. is a world leader in the design, development and marketing of diagnostic test instruments for animal health monitoring and analysis of dairy products and water. Net sales break down by area of application as follows: - veterinary diagnoses for pets (91.6%); - water quality analysis (4.6%); - veterinary diagnoses for livestock and poultry (3.3%): solutions that help detect infectious diseases in ruminants, pigs, poultry and horses. The group also offers test solutions for dairy products; - other (0.5%). Net sales by source of income break down between product sales (57.1%) and services (42.9%). Net sales are distributed geographically as follows: the United States (65.3%), Canada (4.1%), Americas (2.3%), Germany (4.1%), the United Kingdom (3.3%), France (2.7%), Italy (1.5%), Spain (1.4%), Switzerland (0.9%), the Netherlands (0.8%), Europe/Middle East/Africa (4.8%), Australia (2.6%), Japan (2.1%), China (1.2%) and Asia/Pacific (2.9%).
Sector
-
More about the company

Ratings for IDEXX Laboratories, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings

Consensus: IDEXX Laboratories, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
13
Last Close Price
517.9 USD
Average target price
563.8 USD
Spread / Average Target
+8.85%
Consensus